On October 29, Gelonhui announced that Olin Biotech (688319.SH) disclosed that the total amount of funds raised by the company in this issuance of stocks shall not exceed 175.2929 million yuan (including this amount), not more than 0.3 billion yuan and not more than 20% of the net assets at the end of the most recent year. The net proceeds from the funds raised after deducting the relevant issuance expenses are intended to be invested in the following project: the technical renovation project of the vaccine R&D production base.
欧林生物(688319.SH)：拟定增募资不超3亿元
Olin Biology (688319.SH): The proposed additional fundraising will not exceed 0.3 billion yuan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated